These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19327000)

  • 1. PyNTTTTGT prototype oligonucleotide IMT504, a novel effective adjuvant of the FMDV DNA vaccine.
    Zhao G; Jin H; Li J; Su B; Du X; Kang Y; Wang X; Wang B
    Viral Immunol; 2009 Apr; 22(2):131-8. PubMed ID: 19327000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PyNTTTTGT prototype oligonucleotide IMT504 is a potent adjuvant for the recombinant hepatitis B vaccine that enhances the Th1 response.
    Elias F; Flo J; Rodriguez JM; De Nichilo A; Lopez RA; Zorzopulos J; Nagle C; Lahoz M; Montaner A
    Vaccine; 2005 May; 23(27):3597-603. PubMed ID: 15855019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CpG oligodeoxynucleotide and montanide ISA 206 adjuvant combination augments the immune responses of a recombinant FMDV vaccine in cattle.
    Ren J; Yang L; Xu H; Zhang Y; Wan M; Liu G; Zhao L; Wang L; Yu Y
    Vaccine; 2011 Oct; 29(45):7960-5. PubMed ID: 21872635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced protective efficacy and reduced viral load of foot-and-mouth disease DNA vaccine with co-stimulatory molecules as the molecular adjuvants.
    Xiao C; Jin H; Hu Y; Kang Y; Wang J; Du X; Yang Y; She R; Wang B
    Antiviral Res; 2007 Oct; 76(1):11-20. PubMed ID: 17540462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus.
    Wang X; Zhang X; Kang Y; Jin H; Du X; Zhao G; Yu Y; Li J; Su B; Huang C; Wang B
    Vaccine; 2008 Sep; 26(40):5135-44. PubMed ID: 18462848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three CpG oligodeoxynucleotide classes differentially enhance antigen-specific humoral and cellular immune responses in mice.
    Liu Y; Luo X; Yang C; Yu S; Xu H
    Vaccine; 2011 Aug; 29(34):5778-84. PubMed ID: 21664398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses to foot-and-mouth disease DNA vaccines can be enhanced by coinjection with the Isatis indigotica extract.
    Chen L; Lin T; Zhang H; Su Y
    Intervirology; 2005; 48(4):207-12. PubMed ID: 15920343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle.
    Capozzo AV; Wilda M; Bucafusco D; de los Ángeles Lavoria M; Franco-Mahecha OL; Mansilla FC; Pérez-Filgueira DM; Grigera PR
    Antiviral Res; 2011 Nov; 92(2):219-27. PubMed ID: 21889542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PyNTTTTGT and CpG immunostimulatory oligonucleotides: effect on granulocyte/monocyte colony-stimulating factor (GM-CSF) secretion by human CD56+ (NK and NKT) cells.
    Rodriguez JM; Marchicio J; López M; Ziblat A; Elias F; Fló J; López RA; Horn D; Zorzopulos J; Montaner AD
    PLoS One; 2015; 10(2):e0117484. PubMed ID: 25706946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A DNA vaccine encoding foot-and-mouth disease virus B and T-cell epitopes targeted to class II swine leukocyte antigens protects pigs against viral challenge.
    Borrego B; Argilaguet JM; Pérez-Martín E; Dominguez J; Pérez-Filgueira M; Escribano JM; Sobrino F; Rodriguez F
    Antiviral Res; 2011 Nov; 92(2):359-63. PubMed ID: 21820470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha interferon is a powerful adjuvant for a recombinant protein vaccine against foot-and-mouth disease virus in swine, and an effective stimulus of in vivo immune response.
    Cheng G; Zhao X; Yan W; Wang W; Zuo X; Huang K; Liu Y; Chen J; Wang J; Cong W; Liu M; Gao H; Chen J; Lu Y; Zheng Z
    Vaccine; 2007 Jul; 25(28):5199-208. PubMed ID: 17555848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonate Apatite Nanoparticles Act as Potent Vaccine Adjuvant Delivery Vehicles by Enhancing Cytokine Production Induced by Encapsulated Cytosine-Phosphate-Guanine Oligodeoxynucleotides.
    Takahashi H; Misato K; Aoshi T; Yamamoto Y; Kubota Y; Wu X; Kuroda E; Ishii KJ; Yamamoto H; Yoshioka Y
    Front Immunol; 2018; 9():783. PubMed ID: 29720976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective immune responses against foot-and-mouth disease virus by vaccination with a DNA vaccine expressing virus-like particles.
    Jin H; Xiao W; Xiao C; Yu Y; Kang Y; Du X; Wei X; Wang B
    Viral Immunol; 2007 Sep; 20(3):429-40. PubMed ID: 17931113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high dose of IMT504, the PyNTTTTGT prototype immunostimulatory oligonucleotide, does not alter embryonic development in rats.
    Hernando-Insúa A; Rodriguez JM; Elías F; Fló J; López R; Franco R; Lago N; Zorzopulos J; Montaner AD
    Oligonucleotides; 2010 Feb; 20(1):33-6. PubMed ID: 19943802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strong cytosine-guanosine-independent immunostimulation in humans and other primates by synthetic oligodeoxynucleotides with PyNTTTTGT motifs.
    Elias F; Flo J; Lopez RA; Zorzopulos J; Montaner A; Rodriguez JM
    J Immunol; 2003 Oct; 171(7):3697-704. PubMed ID: 14500668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extract from Agaricus blazei Murill can enhance immune responses elicited by DNA vaccine against foot-and-mouth disease.
    Chen L; Shao H
    Vet Immunol Immunopathol; 2006 Jan; 109(1-2):177-82. PubMed ID: 16213597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG ODNs treatments of HIV-1 infected patients may cause the decline of transmission in high risk populations - a review, hypothesis and implications.
    Becker Y
    Virus Genes; 2005 Mar; 30(2):251-66. PubMed ID: 15744581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of IL-6 and TNF-alpha as molecular adjuvants on immune responses to FMDV and maturation of dendritic cells by DNA vaccination.
    Su B; Wang J; Wang X; Jin H; Zhao G; Ding Z; Kang Y; Wang B
    Vaccine; 2008 Sep; 26(40):5111-22. PubMed ID: 18462845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunostimulatory Properties of Lipid Modified CpG Oligonucleotides.
    Yu C; An M; Li M; Liu H
    Mol Pharm; 2017 Aug; 14(8):2815-2823. PubMed ID: 28686452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of synthetic RNA can enhance the immunogenicity of vaccines against foot-and-mouth disease virus (FMDV) in mice.
    Borrego B; Rodríguez-Pulido M; Mateos F; de la Losa N; Sobrino F; Sáiz M
    Vaccine; 2013 Sep; 31(40):4375-81. PubMed ID: 23859841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.